Anna Kersh, MD, PhD
Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737
Headshot of Anna Kersh, MD, PhD
Penn Medicine Provider

About me

  • Assistant Professor of Dermatology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Emory University
  • Residency: Kettering Medical Center
  • Residency: University of Pennsylvania Health System

What my patients think about me

Average Rating

1044 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

February 2026
great discussion and clarity in explaining the symptoms
February 2026
love dr kersh!!! fantastic experience
February 2026
very knowledgeable and professional
February 2026
anna is patient and listens to the patients needs and goes over a plan to help an issues the patient may be having.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Kersh is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Kersh, A.E. and Lobo Lopes, J Trigeminal trophic syndrome , NEJM, 394(10): 2026,e16

Huang J, Sati S, Murphy C, Spencer CA, Rapp E, Prouty SM, Korte S, Ahart O, Sheng E, Jones P, Kersh AE, Leung D, Leung TH. Granulocyte colony stimulating factor promotes scarless tissue regeneration , Cell Rep, 43(10): 2024,114742

Kersh AE, Sati S, Huang J, Murphy C, Ahart O, Leung TH. CXCL9, CXCL10, and CCL19 synergistically recruit T lymphocytes to skin in lichen planus , JCI Insight, 9(20): 2024,e179899

Sati S, Huang J, Kersh AE, Jones P, Ahart O, Murphy C, Prouty SM, Hedberg ML, Jain V, Gregory SG, Leung DH, Seykora JT, Rosenbach M, Leung TH. Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases , J Clin Invest, 134(17): 2024,e178711

Bhattarcharya, S., Sheng, E., Murphy, C., Wei, J., Kersh, A.E., Nelson, C.A., Aschanyan, H.A., Steele, K., Forrestel, A., Seykora, J.T., Micheletti, R.G., James, W.D., Rosenbach, M., Leung, T.H. Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome , J Clin Invest, 133(1): 2023,e162137

Bhattacharya S, Basu S, Sheng E, Murphy C, Wei J, Kersh AE, Nelson CA, Bryer JS, Ashchyan HA, Steele K, Forrestel A, Seykora JT, Micheletti RG, James WD, Rosenbach M, Leung TH. Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome , J Clin Invest, 133: 2023,e162137

Abbott JJ, Jiang AJ, Rauck C, Frank DM, Fortuna D, Kersh A, Rubin AI. Cutaneous metastatic gastric carcinoma with plasmacytoid features: A novel histopathologic pitfall in the diagnosis of primary cutaneous plasmacytoma , J Cutan Pathol, 50(1): 2023,8-11

Torre EA, Kersh AE, Fischer AS, Xu X, Rosenbach M, Shields BE. Angiokeratoma-like purpuric palmar nodules following chemotherapy , Dermatol Online J, 27(8): 2021

Kersh AE, Johansen M, Ojeaga A, de la Feld S. Hand Dermatitis in the Time of COVID-19: A Review of Occupational Irritant Contact Dermatitis , Dermatitis, 32(2): 2021,86-93

Kersh AE, Schuchter LM, Elenitsas R, Chu EY. Hypohidrosis as an immune-related adverse event of checkpoint inhibitor therapy , Immunotherapy, 12(13): 2020,951-956